====== HMS-I1 1μM R01 exp46 ====== ==== Mechanism of Action ==== Inhibits HDAC * **Class / Subclass 1:** Uncharacterized Mechanism / Chemical Screen Hit ==== Technical Notes ==== * **PubChem Name:** %%2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-6-methylimidazo[1,2-a]pyridine%% * **Synonyms:** N/A * **CAS #:** 702636-92-8 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/2813456|2813456]] * **IUPAC:** %%2-(2,3-dihydro-1,4-benzodioxin-6-yl)-6-methylimidazo[1,2-a]pyridine%% * **INCHI Name:** InChI=1S/C16H14N2O2/c1-11-2-5-16-17-13(10-18(16)9-11)12-3-4-14-15(8-12)20-7-6-19-14/h2-5,8-10H,6-7H2,1H3 * **INCHI Key:** ZNAWJWFMKKSTJM-UHFFFAOYSA-N * **Molecular Weight:** 266.29 * **Canonical SMILES:** CC1=CN2C=C(N=C2C=C1)C3=CC4=C(C=C3)OCCO4 * **Isomeric SMILES:** N/A * **Molecular Formula:** C16H14N2O2 {{:chemogenomics:structures:chem-0026.svg?nolink}} * **Supplier Name:** Maybridge * **Catalog #:** HTS 07134 * **Lot #:** N/A * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C16H14N2O2 267.1128; found 267.11196 * **Platform ID:** EMI1 * **Min:** 1.1936; **Max:** 97.3773 {{:chemogenomics:dose_response:dr_79.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |0.5341 | | IC30 |0.9549 | | IC40 |1.5374 | | IC50 |2.3801 | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 01 * **Dose**: 1µM * **Days of incubation**: 8 * **Doublings**: 5.9 * **Numbers of reads**: 11489859 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |3/3|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/HMS-I1_1uM_Round-1_exp46.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp46.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:A:ASPM|ASPM]]|-3.49|0.05| |[[:human_genes:T:TRIP13|TRIP13]]|-3.45|0.02| |[[:human_genes:C:CNOT2|CNOT2]]|-3.25|0.02| |[[:human_genes:K:KNTC1|KNTC1]]|-2.92|0.03| |[[:human_genes:A:ARID4B|ARID4B]]|-2.72|0.13| |[[:human_genes:S:SNX16|SNX16]]|-2.63|0.18| |[[:human_genes:S:SUGT1|SUGT1]]|-2.57|0.45| |[[:human_genes:B:BCORL1|BCORL1]]|-2.56|0.38| |[[:human_genes:C:CUL2|CUL2]]|-2.54|0.29| |[[:human_genes:N:NELFE|NELFE]]|-2.50|0.26| |[[:human_genes:D:DRD3|DRD3]]|-2.49|0.29| |[[:human_genes:M:MAPRE1|MAPRE1]]|-2.46|0.29| |[[:human_genes:T:TCF4|TCF4]]|-2.34|0.26| |[[:human_genes:U:UROD|UROD]]|-2.33|0.29| |[[:human_genes:N:NSMCE1|NSMCE1]]|-2.32|0.42| |[[:human_genes:G:GTSE1|GTSE1]]|-2.30|0.29| |[[:human_genes:C:CDC23|CDC23]]|-2.30|0.42| |[[:human_genes:Y:YARS|YARS]]|-2.30|0.42| |[[:human_genes:A:ACADSB|ACADSB]]|-2.29|0.29| |[[:human_genes:S:SNF8|SNF8]]|-2.26|0.32| |[[:human_genes:P:PSMA8|PSMA8]]|-2.24|0.29| |[[:human_genes:F:FRG2|FRG2]]|-2.23|0.34| |[[:human_genes:F:FIGN|FIGN]]|-2.23|0.29| |[[:human_genes:R:RSPH4A|RSPH4A]]|-2.22|0.42| |[[:human_genes:T:TMEM167A|TMEM167A]]|-2.19|0.57| |[[:human_genes:T:TACC3|TACC3]]|-2.19|0.42| |[[:human_genes:F:FARSB|FARSB]]|-2.17|0.48| |[[:human_genes:E:EED|EED]]|-2.15|0.29| |[[:human_genes:C:CSTA|CSTA]]|-2.15|0.29| |[[:human_genes:I:IKZF4|IKZF4]]|-2.13|0.42| |[[:human_genes:G:GRPEL1|GRPEL1]]|2.28|0.58| |[[:human_genes:E:EGR2|EGR2]]|2.28|0.48| |[[:human_genes:G:GAREM|GAREM]]|2.29|0.41| |[[:human_genes:N:NBPF12|NBPF12]]|2.29|0.58| |[[:human_genes:H:HAUS4|HAUS4]]|2.31|0.31| |[[:human_genes:C:C9orf64|C9orf64]]|2.31|0.58| |[[:human_genes:P:PDSS2|PDSS2]]|2.35|0.28| |[[:human_genes:S:SUPT6H|SUPT6H]]|2.38|0.43| |[[:human_genes:L:LOC100505679|LOC100505679]]|2.39|0.56| |[[:human_genes:D:DZANK1|DZANK1]]|2.41|0.31| |[[:human_genes:S:SRRT|SRRT]]|2.44|0.33| |[[:human_genes:A:ATP6V0C|ATP6V0C]]|2.44|0.42| |[[:human_genes:S:SMC4|SMC4]]|2.45|0.31| |[[:human_genes:Z:ZNF114|ZNF114]]|2.45|0.33| |[[:human_genes:P:PPME1|PPME1]]|2.47|0.31| |[[:human_genes:D:DCUN1D1|DCUN1D1]]|2.47|0.13| |[[:human_genes:O:ORC6|ORC6]]|2.53|0.41| |[[:human_genes:T:TIPRL|TIPRL]]|2.57|0.06| |[[:human_genes:A:AZI1|AZI1]]|2.59|0.14| |[[:human_genes:N:NKAP|NKAP]]|2.61|0.39| |[[:human_genes:T:TP53|TP53]]|2.67|0.13| |[[:human_genes:T:TTL|TTL]]|2.70|0.04| |[[:human_genes:T:TUBB4B|TUBB4B]]|2.72|0.06| |[[:human_genes:I:IER3IP1|IER3IP1]]|2.78|0.42| |[[:human_genes:P:PPP2R5D|PPP2R5D]]|2.80|0.14| |[[:human_genes:L:LCMT1|LCMT1]]|2.87|0.06| |[[:human_genes:P:PMPCA|PMPCA]]|2.89|0.31| |[[:human_genes:P:PPP2R1A|PPP2R1A]]|2.90|0.21| |[[:human_genes:K:KIF18B|KIF18B]]|3.13|<0.01| |[[:human_genes:K:KIF2C|KIF2C]]|3.29|<0.01| ^Screen^Correlation^Plot^ |[[:results:exp59|UMK57 1μM R01 exp59]]|0.12|| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|0.086|| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|0.085|| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|0.069|| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|0.059|| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|0.053|| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|0.091|| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|0.069|| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|0.059|| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|0.058|| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|0.056|| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|0.053|| {{:chemogenomics:comparison_plots:exp46_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp46_vs_exp60.png?nolink |}} {{:chemogenomics:comparison_plots:exp217_vs_exp46.png?nolink |}} {{:chemogenomics:comparison_plots:exp46_vs_exp54.png?nolink |}} {{:chemogenomics:comparison_plots:exp184_vs_exp46.png?nolink |}} {{:chemogenomics:comparison_plots:exp103_vs_exp46.png?nolink |}} {{:chemogenomics:comparison_plots:exp45_vs_exp46.png?nolink |}} {{:chemogenomics:comparison_plots:exp179_vs_exp46.png?nolink |}} {{:chemogenomics:comparison_plots:exp311_vs_exp46.png?nolink |}} {{:chemogenomics:comparison_plots:exp46_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp310_vs_exp46.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp46.png?nolink |}} ^GO Term^Fold Change^Genes^ |regulation of nuclear division|20.82|TRIP13,KNTC1,DRD3,CDC23,PSMA8| |cell cycle process|6.14|ASPM,TRIP13,KNTC1,SUGT1,CUL2,MAPRE1,GTSE1,CDC23,TACC3| No GO term hits below threshold. (FDR <0.05)